Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Neuropsychopharmacology. 2016 Nov 24;42(5):1169–1177. doi: 10.1038/npp.2016.265

Table 1.

Main demographic characteristics of the studied sample. Values are means (SD) or n.

HC PG BED P-value1
n 17 15 7
Age (years) 43.3 (11.1) 42.6 (11.8) 49.4 (5.1) 0.35
Sex (m/f) 8/9 8/7 0/7 0.048
BMI (kg/m2) 24.8 (2.1) 25.4 (3.6) 30.9 (6.6) 0.003
Smoking (y/n) 7/10 11/4 2/5 0.08
BDI 2.8 (3.1) 14.4 (7.8) 15.4 (9.6) <0.0001
Injected dose of [11C]carfentanil (MBq) 495 (17) 483 (49) 504 (13) 0.35
Injected mass of [11C]carfentanil (µg) 0.428 (0.307) 0.569 (0.542) 0.422 (0.197) 0.56
Injected dose of [18F]fluorodopa (MBq) 228 (4) 229 (12) 225 (6) 0.67
Injected mass of [18F]fluorodopa (µg) 9.30 (3.31) 11.28 (3.59) 10.54 (5.88) 0.40
AUDIT 5.4 (3.3) 5.9 (4.0) 3.3 (1.1) 0.23
1

One-way ANOVA or Chi-Square test

BMI= body mass index, BDI= Beck Depression Inventory, AUDIT= Alcohol Use Disorders Identification Test